Insiders Updates Wells Fargo Upgrades C4 Therapeutics Inc (CCCC) to an Overweight from an Equal weight C4 Therapeutics Inc’s filing revealed that its Chief Business Officer Boyle Scott N unloaded Company’s shares for reported $2107.0 on
Analysts Viewpoint C4 Therapeutics Inc [CCCC] stock was sold by Boyle Scott N at the price of US$2107.0 In a filing, C4 Therapeutics Inc revealed its Chief Business Officer Boyle Scott N unloaded Company’s shares for reported $2107.0